Parisi Gray Wealth Management Lowers Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Parisi Gray Wealth Management lessened its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 69.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 351 shares of the health services provider’s stock after selling 792 shares during the period. Parisi Gray Wealth Management’s holdings in Teladoc Health were worth $58,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. Bellecapital International Ltd. boosted its position in Teladoc Health by 3.3% during the second quarter. Bellecapital International Ltd. now owns 2,054 shares of the health services provider’s stock worth $342,000 after purchasing an additional 66 shares during the period. Cullen Frost Bankers Inc. boosted its stake in Teladoc Health by 43.9% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 226 shares of the health services provider’s stock worth $38,000 after purchasing an additional 69 shares during the period. GPS Wealth Strategies Group LLC grew its holdings in Teladoc Health by 1.5% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 5,140 shares of the health services provider’s stock valued at $855,000 after buying an additional 74 shares in the last quarter. Eudaimonia Partners LLC increased its position in shares of Teladoc Health by 1.9% during the first quarter. Eudaimonia Partners LLC now owns 4,191 shares of the health services provider’s stock valued at $762,000 after buying an additional 77 shares during the period. Finally, Kovack Advisors Inc. lifted its holdings in shares of Teladoc Health by 2.2% in the second quarter. Kovack Advisors Inc. now owns 3,675 shares of the health services provider’s stock worth $611,000 after buying an additional 78 shares in the last quarter. 79.43% of the stock is owned by hedge funds and other institutional investors.

NYSE TDOC opened at $137.48 on Thursday. The business’s 50 day moving average price is $138.60 and its 200-day moving average price is $152.83. Teladoc Health, Inc. has a fifty-two week low of $120.67 and a fifty-two week high of $308.00. The company has a market cap of $21.89 billion, a P/E ratio of -23.99 and a beta of 0.24. The company has a debt-to-equity ratio of 0.08, a quick ratio of 3.79 and a current ratio of 4.00.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Tuesday, July 27th. The health services provider reported ($0.86) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.59) by ($0.27). The firm had revenue of $503.14 million during the quarter, compared to analysts’ expectations of $499.85 million. Teladoc Health had a negative net margin of 46.86% and a negative return on equity of 1.29%. The company’s revenue was up 108.7% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.34) EPS. As a group, equities analysts predict that Teladoc Health, Inc. will post -3.53 EPS for the current year.

A number of brokerages have weighed in on TDOC. Craig Hallum decreased their target price on Teladoc Health from $202.00 to $165.00 and set a “hold” rating on the stock in a research note on Wednesday, July 28th. KeyCorp lowered their price target on shares of Teladoc Health from $220.00 to $180.00 and set an “overweight” rating for the company in a research note on Wednesday, July 28th. BTIG Research dropped their price objective on Teladoc Health from $300.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday, July 28th. Oppenheimer dropped their price target on Teladoc Health from $250.00 to $220.00 and set an “outperform” rating for the company in a research note on Wednesday, July 28th. Finally, Citigroup reduced their price objective on shares of Teladoc Health from $260.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 28th. Twelve analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, Teladoc Health presently has a consensus rating of “Buy” and a consensus price target of $217.75.

In other news, insider Arnnon Geshuri sold 4,050 shares of the stock in a transaction on Thursday, August 26th. The shares were sold at an average price of $143.29, for a total value of $580,324.50. Following the sale, the insider now owns 88,908 shares in the company, valued at $12,739,627.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jason N. Gorevic sold 10,000 shares of Teladoc Health stock in a transaction that occurred on Tuesday, August 3rd. The shares were sold at an average price of $150.12, for a total transaction of $1,501,200.00. The disclosure for this sale can be found here. Insiders sold a total of 17,470 shares of company stock worth $2,609,504 over the last three months. 6.47% of the stock is currently owned by corporate insiders.

Teladoc Health Profile

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Featured Story: What is basic economics?

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.